NCT00073307View on ClinicalTrials.gov

Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

903

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

September 30, 2006

Study Completion Date

April 30, 2010

Conditions

Carcinoma, Renal Cell

Interventions

DRUG

Sorafenib (Nexavar, BAY43-9006)

Multi Kinase Inhibitor

DRUG

Placebo

Placebo

Trial Locations (121)

115

Kiev

1000

Bruxelles - Brussel

1032

Budapest

1090

Bruxelles - Brussel

1121

Budapest

2050

Camperdown

2145

Westmead

2170

Liverpool

2605

Garran

3084

Heidelberg

4001

Durban

4004

Debrecen

5500

Mendoza

7500

Cape Town

8900

Zalaegerszeg

9300

Bloemfontein

10032

New York

10967

Berlin

11220

Brooklyn

13273

Marseille

14076

Caen

20133

Milan

20246

Hamburg

21701

Frederick

23229

Richmond

27100

Pavia

28040

Madrid

29303

Spartanburg

30309

Atlanta

31052

Toulouse

33000

Bordeaux

36024

Poltava

40202

Louisville

40225

Düsseldorf

41124

Modena

42100

Reggio Emilia

44195

Cleveland

44718

Canton

44805

Nantes

45429

Dayton

46009

Valencia

48903

Cruces/Barakaldo

55455

Minneapolis

59020

Lille

60488

Frankfurt am Main

60637

Chicago

61024

Kharkiv

64239

Tel Aviv

64276

Darmstadt

67091

Strasbourg

68167

Mannheim

69008

Lyon

70506

Lafayette

75246

Dallas

75908

Paris

78041

Laredo

78212

San Antonio

79031

Lviv

80045

Aurora

81377

München

83092

Donetsk

84132

Salt Lake City

85712

Tucson

89075

Ulm

90033

Los Angeles

90057

Los Angeles

93042

Regensburg

94805

Villejuif

95817

Sacramento

97239

Portland

98101

Seattle

115478

Moscow

125284

Moscow

198255

Saint Petersburg

249036

Obninsk

420029

Kazan'

610021

Kirov

656049

Barnaul

3109601

Haifa

90619900

Porto Alegre

06518

Hamden

02215

Boston

65203-3244

Columbia

63110-1093

St Louis

10466-2604

The Bronx

19107-5096

Philadelphia

53226-3596

Milwaukee

S2000DSK

Rosario

S3000FFV

Santa Fé

C1426ANZ

Capital Federal-Buenos Aires

0390

Wodonga

81520-060

Curitiba

90020-060

Porto Alegre

T6G 1Z2

Edmonton

L8V 5C2

Hamilton

N6A 4L6

London

M5G 2M9

Toronto

H3T 1E2

Montreal

Unknown

Santiago

Pretoria

01307

Dresden

06122

Perugia

00144

Roma

6525 GA

Nijmegen

80-210

Gdansk

31-115

Krakow

93-509

Lodz

20-090

Lublin

61-878

Poznan

70-111

Szczecin

02-781

Warsaw

04-141

Warsaw

50-043

Wroclaw

08035

Barcelona

M20 4BX

Manchester

HA6 2RN

Northwood

CF14 2TL

Cardiff

G11 6NT

Glasgow

SM2 5PT

Sutton

NE4 6BE

Newcastle upon Tyne

B15 2TT

Birmingham

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Amgen

INDUSTRY

lead

Bayer

INDUSTRY